{"data":{"id":856,"lang":"en","title":"New Single-Dose Drug Acoziborole Could End Sleeping Sickness, EMA Gives Green Light","summary":"EMA approves acoziborole, a single-dose drug that could eliminate sleeping sickness by 2030, replacing treatments that killed 1 in 20 patients.","category":"science","category_label":"Science","published_at":"2026-03-17T12:02:03Z","updated_at":"2026-03-17T12:02:03Z","url":"https://techtools.cz/tools/news/article/856-new-single-dose-drug-acoziborole-could-end-sleeping-sickness-ema-gives-green","api_url":"https://techtools.cz/news-api/v1/articles/856?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/856.md?lang=en","image_url":"https://npr.brightspotcdn.com/dims3/default/strip/false/crop/3072x2048+0+0/resize/1100/quality/50/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F45%2Fed%2F4889d3be4675b8c9944a26bb295d%2Fgettyimages-542335176.jpg","word_count":158,"reading_time_minutes":1,"sources":[{"url":"https://www.npr.org/2026/03/16/g-s1-113246/sleeping-sickness-drug-treatment-tsetse-fly","domain":"npr.org"}],"translation":{"lang":"cs","id":883,"title":"Nový jednodávkový lék acoziborol může ukončit spavou nemoc, Evropská léková agentura dala zelenou","url":"https://techtools.cz/tools/news/clanek/883-novy-jednodavkovy-lek-acoziborol-muze-ukoncit-spavou-nemoc-evropska-lekova","api_url":"https://techtools.cz/news-api/v1/articles/883?lang=cs"},"content":"The European Medicines Agency has given a key approval to acoziborole, the first single-dose treatment for sleeping sickness — a parasitic disease transmitted by tsetse flies that kills thousands across sub-Saharan Africa each year. The drug, developed by the Drugs for Neglected Diseases Initiative (DNDi) and Sanofi with Gates Foundation funding, consists of just three pills taken at once.\n\nAcoziborole replaces previous treatments that required intravenous drugs causing burning sensations in veins and killing nearly 1 in 20 patients, or a 10-day regimen with severe side effects including nausea and heart-rhythm disturbances. The new drug treats both stages of the disease — including the deadly neurological phase after the parasite crosses the blood-brain barrier — with only mild headache as a significant side effect.\n\nThe WHO aims to eliminate sleeping sickness by 2030, and acoziborole could be the breakthrough that makes it possible. The drug dramatically simplifies treatment in remote African communities where access to hospitals with IV equipment is limited."}}